NCT02113982 · BASELINE
Baseline characteristics
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- denoms
- counts
- group Id
- BG000
- value
- 6
- group Id
- BG001
- value
- 13
- group Id
- BG002
- value
- 13
- group Id
- BG003
- value
- 36
- group Id
- BG004
- value
- 3
- group Id
- BG005
- value
- 10
- group Id
- BG006
- value
- 6
- group Id
- BG007
- value
- 14
- group Id
- BG008
- value
- 35
- group Id
- BG009
- value
- 136
- units
- Participants
- groups
- description
- Dose Escalation, 7 or 12 µg/kg/day of Tagraxofusp as IV over 15 minutes for up to 5 consecutive days of a 21-day cycle
- id
- BG000
- title
- First-line BPDCN- Stage 1
- description
- Administration of 12 µg/kg/day of Tagraxofusp as IV over 15 minutes for up to 5 consecutive days of a 21-day cycle
- id
- BG001
- title
- First-line BPDCN - Stage 2
- description
- Administration of 12 µg/kg/day of Tagraxofusp as IV over 15 minutes for up to 5 consecutive days of a 21-day cycle
- id
- BG002
- title
- First-line BPDCN - Stage 3
- description
- Administration of 12 µg/kg/day of Tagraxofusp as IV over 15 minutes for up to 5 consecutive days of a 21-day cycle
- id
- BG003
- title
- First-line BPDCN - Stage 4
- description
- Dose Escalation, 12 µg/kg/ day of Tagraxofusp as IV over 15 minutes for up to 5 consecutive days of a 21-day cycle
- id
- BG004
- title
- R/R BPDCN - Stage 1
- description
- Administration of 12 µg/kg/day of Tagraxofusp as IV over 15 minutes for up to 5 consecutive days of a 21-day cycle
- id
- BG005
- title
- R/R BPDCN - Stage 2
- description
- Administration of 12 µg/kg/day of Tagraxofusp as IV over 15 minutes for up to 5 consecutive days of a 21-day cycle
- id
- BG006
- title
- R/R BPDCN - Stage 4
- description
- Dose Escalation 7, 9,12 or 16 µg/kg/ day of Tagraxofusp as IV over 15 minutes for up to 5 consecutive days of a 21-day cycle
- id
- BG007
- title
- AML - Stage 1
- description
- Administration of 12 µg/kg/ day of Tagraxofusp as IV over 15 minutes for up to 5 consecutive days of a 21-day cycle
- id
- BG008
- title
- AML - Stage 2
- description
- Total of all reporting groups
- id
- BG009
- title
- Total
- measures
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 10.49
- value
- 67
- group Id
- BG001
- spread
- 17.72
- value
- 62.5
- group Id
- BG002
- spread
- 17.15
- value
- 61.7
- group Id
- BG003
- spread
- 14.71
- value
- 64.1
- group Id
- BG004
- spread
- 7.94
- value
- 72
- group Id
- BG005
- spread
- 9.31
- value
- 69.7
- group Id
- BG006
- spread
- 15.32
- value
- 67.5
- group Id
- BG007
- spread
- 11.17
- value
- 58.6
- group Id
- BG008
- spread
- 16.01
- value
- 61.2
- group Id
- BG009
- spread
- 14.64
- value
- 63.4
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- title
- Age, Continuous
- unit Of Measure
- years
- classes
- categories
- measurements
- group Id
- BG000
- value
- 1
- group Id
- BG001
- value
- 3
- group Id
- BG002
- value
- 2
- group Id
- BG003
- value
- 7
- group Id
- BG004
- value
- 0
- group Id
- BG005
- value
- 2
- group Id
- BG006
- value
- 1
- group Id
- BG007
- value
- 7
- group Id
- BG008
- value
- 13
- group Id
- BG009
- value
- 36
- title
- Female
- measurements
- group Id
- BG000
- value
- 5
- group Id
- BG001
- value
- 10
- group Id
- BG002
- value
- 11
- group Id
- BG003
- value
- 29
- group Id
- BG004
- value
- 3
- group Id
- BG005
- value
- 8
- group Id
- BG006
- value
- 5
- group Id
- BG007
- value
- 7
- group Id
- BG008
- value
- 22
- group Id
- BG009
- value
- 100
- title
- Male
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Sex: Female, Male
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 5
- group Id
- BG001
- value
- 12
- group Id
- BG002
- value
- 13
- group Id
- BG003
- value
- 30
- group Id
- BG004
- value
- 2
- group Id
- BG005
- value
- 10
- group Id
- BG006
- value
- 5
- group Id
- BG007
- value
- 12
- group Id
- BG008
- value
- 31
- group Id
- BG009
- value
- 120
- title
- White
- categories
- measurements
- group Id
- BG000
- value
- 1
- group Id
- BG001
- value
- 1
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 6
- group Id
- BG004
- value
- 1
- group Id
- BG005
- value
- 0
- group Id
- BG006
- value
- 1
- group Id
- BG007
- value
- 2
- group Id
- BG008
- value
- 4
- group Id
- BG009
- value
- 16
- title
- Other
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Race/Ethnicity, Customized
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 3
- group Id
- BG001
- value
- 6
- group Id
- BG002
- value
- 8
- group Id
- BG003
- value
- 16
- group Id
- BG004
- value
- 1
- group Id
- BG005
- value
- 4
- group Id
- BG006
- value
- 2
- group Id
- BG007
- value
- 5
- group Id
- BG008
- value
- 6
- group Id
- BG009
- value
- 51
- title
- ECOG 0
- categories
- measurements
- group Id
- BG000
- value
- 3
- group Id
- BG001
- value
- 7
- group Id
- BG002
- value
- 5
- group Id
- BG003
- value
- 17
- group Id
- BG004
- value
- 2
- group Id
- BG005
- value
- 6
- group Id
- BG006
- value
- 4
- group Id
- BG007
- value
- 8
- group Id
- BG008
- value
- 26
- group Id
- BG009
- value
- 78
- title
- ECOG 1
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 2
- group Id
- BG004
- value
- 0
- group Id
- BG005
- value
- 0
- group Id
- BG006
- value
- 0
- group Id
- BG007
- value
- 1
- group Id
- BG008
- value
- 2
- group Id
- BG009
- value
- 5
- title
- ECOG 2
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 1
- group Id
- BG004
- value
- 0
- group Id
- BG005
- value
- 0
- group Id
- BG006
- value
- 0
- group Id
- BG007
- value
- 0
- group Id
- BG008
- value
- 1
- group Id
- BG009
- value
- 2
- title
- Missing
- description
- Grade 0 Able to carry out all normal activities without restriction. Grade 1 Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature. Grade 2 Ambulatory and capable of all self-care but unable to carry out any work activities: up and about more than 50% of waking hours. Grade 3 Capable of limited self-care; confined to bed or chair more than 50% of waking hours. Grade 4 Completely disabled; cannot carry on self-care; totally confined to bed or chair.
- param Type
- COUNT_OF_PARTICIPANTS
- title
- ECOG Performance Status Scale
- unit Of Measure
- Participants
- population Description
- modified ITT (mITT): all patients with blastic plasmacytoid dendritic cell neoplasm (first-line or relapsed/refractory) and acute myeloid leukemia who were eligible based on the screening criteria and who received at least 1 dose of tagraxofusp, excluding 2 patients who withdrew from study before first response assessment. Total mITT=136. Baseline characteristics data collected by disease and study stage only.
Complete source fields
- denoms
- counts
- group Id
- BG000
- value
- 6
- group Id
- BG001
- value
- 13
- group Id
- BG002
- value
- 13
- group Id
- BG003
- value
- 36
- group Id
- BG004
- value
- 3
- group Id
- BG005
- value
- 10
- group Id
- BG006
- value
- 6
- group Id
- BG007
- value
- 14
- group Id
- BG008
- value
- 35
- group Id
- BG009
- value
- 136
- units
- Participants
- groups
- description
- Dose Escalation, 7 or 12 µg/kg/day of Tagraxofusp as IV over 15 minutes for up to 5 consecutive days of a 21-day cycle
- id
- BG000
- title
- First-line BPDCN- Stage 1
- description
- Administration of 12 µg/kg/day of Tagraxofusp as IV over 15 minutes for up to 5 consecutive days of a 21-day cycle
- id
- BG001
- title
- First-line BPDCN - Stage 2
- description
- Administration of 12 µg/kg/day of Tagraxofusp as IV over 15 minutes for up to 5 consecutive days of a 21-day cycle
- id
- BG002
- title
- First-line BPDCN - Stage 3
- description
- Administration of 12 µg/kg/day of Tagraxofusp as IV over 15 minutes for up to 5 consecutive days of a 21-day cycle
- id
- BG003
- title
- First-line BPDCN - Stage 4
- description
- Dose Escalation, 12 µg/kg/ day of Tagraxofusp as IV over 15 minutes for up to 5 consecutive days of a 21-day cycle
- id
- BG004
- title
- R/R BPDCN - Stage 1
- description
- Administration of 12 µg/kg/day of Tagraxofusp as IV over 15 minutes for up to 5 consecutive days of a 21-day cycle
- id
- BG005
- title
- R/R BPDCN - Stage 2
- description
- Administration of 12 µg/kg/day of Tagraxofusp as IV over 15 minutes for up to 5 consecutive days of a 21-day cycle
- id
- BG006
- title
- R/R BPDCN - Stage 4
- description
- Dose Escalation 7, 9,12 or 16 µg/kg/ day of Tagraxofusp as IV over 15 minutes for up to 5 consecutive days of a 21-day cycle
- id
- BG007
- title
- AML - Stage 1
- description
- Administration of 12 µg/kg/ day of Tagraxofusp as IV over 15 minutes for up to 5 consecutive days of a 21-day cycle
- id
- BG008
- title
- AML - Stage 2
- description
- Total of all reporting groups
- id
- BG009
- title
- Total
- measures
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 10.49
- value
- 67
- group Id
- BG001
- spread
- 17.72
- value
- 62.5
- group Id
- BG002
- spread
- 17.15
- value
- 61.7
- group Id
- BG003
- spread
- 14.71
- value
- 64.1
- group Id
- BG004
- spread
- 7.94
- value
- 72
- group Id
- BG005
- spread
- 9.31
- value
- 69.7
- group Id
- BG006
- spread
- 15.32
- value
- 67.5
- group Id
- BG007
- spread
- 11.17
- value
- 58.6
- group Id
- BG008
- spread
- 16.01
- value
- 61.2
- group Id
- BG009
- spread
- 14.64
- value
- 63.4
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- title
- Age, Continuous
- unit Of Measure
- years
- classes
- categories
- measurements
- group Id
- BG000
- value
- 1
- group Id
- BG001
- value
- 3
- group Id
- BG002
- value
- 2
- group Id
- BG003
- value
- 7
- group Id
- BG004
- value
- 0
- group Id
- BG005
- value
- 2
- group Id
- BG006
- value
- 1
- group Id
- BG007
- value
- 7
- group Id
- BG008
- value
- 13
- group Id
- BG009
- value
- 36
- title
- Female
- measurements
- group Id
- BG000
- value
- 5
- group Id
- BG001
- value
- 10
- group Id
- BG002
- value
- 11
- group Id
- BG003
- value
- 29
- group Id
- BG004
- value
- 3
- group Id
- BG005
- value
- 8
- group Id
- BG006
- value
- 5
- group Id
- BG007
- value
- 7
- group Id
- BG008
- value
- 22
- group Id
- BG009
- value
- 100
- title
- Male
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Sex: Female, Male
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 5
- group Id
- BG001
- value
- 12
- group Id
- BG002
- value
- 13
- group Id
- BG003
- value
- 30
- group Id
- BG004
- value
- 2
- group Id
- BG005
- value
- 10
- group Id
- BG006
- value
- 5
- group Id
- BG007
- value
- 12
- group Id
- BG008
- value
- 31
- group Id
- BG009
- value
- 120
- title
- White
- categories
- measurements
- group Id
- BG000
- value
- 1
- group Id
- BG001
- value
- 1
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 6
- group Id
- BG004
- value
- 1
- group Id
- BG005
- value
- 0
- group Id
- BG006
- value
- 1
- group Id
- BG007
- value
- 2
- group Id
- BG008
- value
- 4
- group Id
- BG009
- value
- 16
- title
- Other
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Race/Ethnicity, Customized
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 3
- group Id
- BG001
- value
- 6
- group Id
- BG002
- value
- 8
- group Id
- BG003
- value
- 16
- group Id
- BG004
- value
- 1
- group Id
- BG005
- value
- 4
- group Id
- BG006
- value
- 2
- group Id
- BG007
- value
- 5
- group Id
- BG008
- value
- 6
- group Id
- BG009
- value
- 51
- title
- ECOG 0
- categories
- measurements
- group Id
- BG000
- value
- 3
- group Id
- BG001
- value
- 7
- group Id
- BG002
- value
- 5
- group Id
- BG003
- value
- 17
- group Id
- BG004
- value
- 2
- group Id
- BG005
- value
- 6
- group Id
- BG006
- value
- 4
- group Id
- BG007
- value
- 8
- group Id
- BG008
- value
- 26
- group Id
- BG009
- value
- 78
- title
- ECOG 1
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 2
- group Id
- BG004
- value
- 0
- group Id
- BG005
- value
- 0
- group Id
- BG006
- value
- 0
- group Id
- BG007
- value
- 1
- group Id
- BG008
- value
- 2
- group Id
- BG009
- value
- 5
- title
- ECOG 2
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 1
- group Id
- BG004
- value
- 0
- group Id
- BG005
- value
- 0
- group Id
- BG006
- value
- 0
- group Id
- BG007
- value
- 0
- group Id
- BG008
- value
- 1
- group Id
- BG009
- value
- 2
- title
- Missing
- description
- Grade 0 Able to carry out all normal activities without restriction. Grade 1 Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature. Grade 2 Ambulatory and capable of all self-care but unable to carry out any work activities: up and about more than 50% of waking hours. Grade 3 Capable of limited self-care; confined to bed or chair more than 50% of waking hours. Grade 4 Completely disabled; cannot carry on self-care; totally confined to bed or chair.
- param Type
- COUNT_OF_PARTICIPANTS
- title
- ECOG Performance Status Scale
- unit Of Measure
- Participants
- population Description
- modified ITT (mITT): all patients with blastic plasmacytoid dendritic cell neoplasm (first-line or relapsed/refractory) and acute myeloid leukemia who were eligible based on the screening criteria and who received at least 1 dose of tagraxofusp, excluding 2 patients who withdrew from study before first response assessment. Total mITT=136. Baseline characteristics data collected by disease and study stage only.
Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0
Preserved source evidence · Not medical advice
Triangle